Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Thromboembolic Events”

325 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 325 results

Not applicableStudy completedNCT01046903
What this trial is testing

An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®

Who this might be right for
Venous Thromboembolism
Pfizer 503
Not applicableActive Not RecruitingNCT06193863
What this trial is testing

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Who this might be right for
Prevention of Venous ThromboembolismCongenital Heart DiseaseFontan Procedure+1 more
Bayer 61
Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Large-scale testing (Phase 3)Study completedNCT03395639
What this trial is testing

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Who this might be right for
Cardiac Disease
Daiichi Sankyo 168
Not applicableActive Not RecruitingNCT05396157
What this trial is testing

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

Who this might be right for
Thrombosis, VenousBleeding HemorrhageVenous Thromboembolic Disease+2 more
Mount Sinai Hospital, Canada 813
Not applicableStudy completedNCT00810784
What this trial is testing

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

Who this might be right for
Venous Thromboembolism
University of Utah 121
Testing effectiveness (Phase 2)Study completedNCT01835990
What this trial is testing

Feasibility Study of Geko vs. IPCs in Trauma

Who this might be right for
TraumaVenous Thromboembolism
Hamilton Health Sciences Corporation 20
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Large-scale testing (Phase 3)UnknownNCT04999176
What this trial is testing

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Who this might be right for
CancerRivaroxabanVenous Thromboembolism+1 more
André Luiz Malavasi Longo de Oliveira 440
Large-scale testing (Phase 3)Ended earlyNCT03090880
What this trial is testing

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

Who this might be right for
Venous ThromboembolismLung Neoplasm
Assistance Publique - Hôpitaux de Paris 59
Testing effectiveness (Phase 2)Study completedNCT04850378
What this trial is testing

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeThromboembolic Disease
University of Aarhus 57
Not applicableStudy completedNCT01303523
What this trial is testing

Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort

Who this might be right for
Leg InjuriesWinter Sport ResortsOutpatients
Floralis 1,627
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Post-approval studies (Phase 4)UnknownNCT02295150
What this trial is testing

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Who this might be right for
Morbid ObesityThromboembolismBypass Complications
Rijnstate Hospital 50
Not applicableStudy completedNCT00831714
What this trial is testing

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Bayer 19,076
Large-scale testing (Phase 3)Study completedNCT00244426
What this trial is testing

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Pfizer 1,372
Large-scale testing (Phase 3)Looking for participantsNCT07005024
What this trial is testing

DOAC - Dosing Options in AntiCoagulation Prophylaxis

Who this might be right for
CancerVTE (Venous Thromboembolism)
University of Vermont 996
Testing effectiveness (Phase 2)Ended earlyNCT00790452
What this trial is testing

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)Ended earlyNCT02396732
What this trial is testing

Aspirin and Enoxaparin for VTE in Trauma

Who this might be right for
Venous ThromboembolismThromboprophylaxisTrauma
University of Miami 31
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Next Page